Back

Risk factors for cardiometabolic multimorbidity: an analysis of 4 million participants from May Measurement Month 2017-2019

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk factors and lifestyle modification in hypertension Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Carolina Janssen Telders

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Treadmill exercise test as a screening tool in the development of hypertension
Mr T. Kalos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Effect of DASH vs. Mediterranean diet on metabolic syndrome and cardiometabolic profile in adults with high normal blood pressure or grade 1 hypertension: the DASH-MedDiet randomized controlled trial
Doctor C. Filippou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Arterial hypertension in the era of obesity bias: the impact of obesity status on pharmacological treatment intensification in patients with diabetes
Doctor G. Telo (Porto Alegre, BR)
Abstract Slides Video
Presentation thumbnail
The importance of taste salt sensitivity in the development of kidney damage in patients with high-risked arterial hypertension
Doctor G. Khamidullaeva (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Cumulative effect of lifetime smoking history on arterial stiffness and subclinical atherosclerosis in patients with arterial hypertension
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and lifestyle modification in hypertension

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Cardiometabolic multimorbidity and associated risk factors in a cohort identified through community-based screening in Eastern Nepal.
thumbnail
Congress Presentation
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: data from the RACE II study
thumbnail
Congress Presentation
Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources